Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioMarin Pharmaceutical Company Profile (NASDAQ:BMRN)

Consensus Ratings for BioMarin Pharmaceutical (NASDAQ:BMRN) (?)
Ratings Breakdown: 2 Hold Rating(s), 17 Buy Rating(s)
Consensus Rating:Buy (Score: 2.89)
Consensus Price Target: $120.80 (3.80% downside)

Current Analysts' Coverage Summary for BioMarin Pharmaceutical (NASDAQ:BMRN)
Show:
DateFirmActionRatingPrice TargetActions
5/28/2015Cowen and CompanyBoost Price TargetOutperform$125.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015JPMorgan Chase & Co.Boost Price TargetOverweight$125.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015WedbushReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Jefferies GroupReiterated RatingBuy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2015Piper JaffrayReiterated RatingOverweight$123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Deutsche BankBoost Price TargetBuy$90.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Canaccord GenuitySet Price TargetBuy$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Citigroup Inc.Reiterated RatingBuy$94.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Leerink SwannBoost Price TargetOutperform$107.00 -> $136.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015Bank of AmericaInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Evercore ISIInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/23/2015Robert W. BairdBoost Price TargetOutperform$95.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2015NomuraReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015RBC CapitalSet Price TargetBuy$110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2014Goldman SachsUpgradeNeutral -> Buy$78.00 -> $104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014Credit SuisseReiterated RatingOutperform$74.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2014SunTrustInitiated CoverageBuy$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2014BarclaysBoost Price TargetEqual Weight$73.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013HSBCBoost Price TargetOverweight$46.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2013William BlairReiterated RatingHold$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2013Stifel NicolausDowngradeBuy -> Hold$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2013 forward)